Technical Analysis for AKCA - Akcea Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 29.975 -2.17% -0.67
AKCA closed down 0.29 percent on Tuesday, January 15, 2019, on 36 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical AKCA trend table...

Date Alert Name Type % Chg
Jan 15 Down 3 Days in a Row Weakness -2.17%
Jan 14 Overbought Stochastic Strength -2.46%
Jan 11 Stochastic Sell Signal Bearish -6.03%
Jan 11 Overbought Stochastic Strength -6.03%
Jan 10 Pocket Pivot Bullish Swing Setup -9.25%
Jan 10 Overbought Stochastic Strength -9.25%
Jan 9 Stochastic Reached Overbought Strength -7.68%
Jan 9 Inside Day Range Contraction -7.68%
Jan 9 Overbought Stochastic Strength -7.68%
Jan 7 Crossed Above 20 DMA Bullish -7.37%

Older signals for AKCA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. (Ionis). The Company's volanesorsen drug has completed a Phase III clinical program for the treatment of familial chylomicronemia syndrome (FCS) and is currently in Phase III clinical development for the treatment of familial partial lipodystrophy (FPL). The Company's clinical pipeline contains drugs with the potential to treat inadequately addressed lipid disorders beyond elevated LDL-C that are contributing to the dramatic increase in the incidence of cardiometabolic disease, such as elevated triglycerides, oxidized phospholipids and other lipoproteins, such as lipoprotein(a), or Lp(a).
Is AKCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 40.75
52 Week Low 15.73
Average Volume 255,643
200-Day Moving Average 27.5784
50-Day Moving Average 29.7532
20-Day Moving Average 29.9505
10-Day Moving Average 31.388
Average True Range 1.9968
ADX 14.59
+DI 22.2805
-DI 20.6045
Chandelier Exit (Long, 3 ATRs ) 27.9896
Chandelier Exit (Short, 3 ATRs ) 31.2604
Upper Bollinger Band 33.8666
Lower Bollinger Band 26.0344
Percent B (%b) 0.59
BandWidth 26.150482
MACD Line 0.5182
MACD Signal Line 0.4261
MACD Histogram 0.0921
Fundamentals Value
Market Cap 1.96 Billion
Num Shares 63.9 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -16.21
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.89
Resistance 3 (R3) 33.03 32.43 32.52
Resistance 2 (R2) 32.43 31.85 32.36 32.39
Resistance 1 (R1) 31.53 31.50 31.23 31.39 32.26
Pivot Point 30.93 30.93 30.78 30.86 30.93
Support 1 (S1) 30.03 30.35 29.73 29.89 29.02
Support 2 (S2) 29.43 30.00 29.36 28.89
Support 3 (S3) 28.53 29.43 28.77
Support 4 (S4) 28.39